These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7298289)

  • 21. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of recurrent calcium stone formation with cellulose phosphate.
    Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström B
    J Urol; 1980 Jan; 123(1):9-13. PubMed ID: 7351731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
    Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hydrochlorothiazide on urine saturation with brushite, in vitro collagen calcification by urine, and urinary inhibitors of collagen calcification.
    Pylypchuk G; Ehrig U; Wilson DR
    Can Med Assoc J; 1978 Apr; 118(7):792-6. PubMed ID: 638910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of calcium, aluminium, magnesium and cholestyramine on hyperoxaluria in patients with jejunoileal bypass.
    Nordenvall B; Backman L; Larsson L; Tiselius HG
    Acta Chir Scand; 1983; 149(1):93-8. PubMed ID: 6837229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies of calcium metabolism in normal persons and patients with hypercalciuria in relation to therapy with the dietary fiber preparation Farnolith].
    Strohmaier WL; Bichler KH; Kalchthaler M
    Urologe A; 1989 Jan; 28(1):11-4. PubMed ID: 2538020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias. Effect of calcium and magnesium.
    Barilla DE; Notz C; Kennedy D; Pak CY
    Am J Med; 1978 Apr; 64(4):579-85. PubMed ID: 645724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis.
    Damasio B; Massarino F; Durand F; Banchero R; Bottino P; De Franchis V; Carmignani G; Cannella G
    J Nephrol; 2005; 18(3):262-6. PubMed ID: 16013013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacology of sodium cellulose phosphate.
    Pak CY
    J Clin Pharmacol; 1979; 19(8-9 Pt 1):451-7. PubMed ID: 489764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rice bran in the treatment of idiopathic hypercalciuria in patients with urinary calculosis].
    Noronha IL; Andriolo A; Lucon AM; Wroclawski ER; Chade J; Borelli A; Leite MO; Sabbaga E; Arap S
    Rev Paul Med; 1989; 107(1):19-24. PubMed ID: 2616974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of oral administration of calcium and magnesium on intestinal oxalate absorption in humans.
    Voss S; Zimmermann DJ; Hesse A; von Unruh GE
    Isotopes Environ Health Stud; 2004 Sep; 40(3):199-205. PubMed ID: 15370283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol.
    Levy FL; Adams-Huet B; Pak CY
    Am J Med; 1995 Jan; 98(1):50-9. PubMed ID: 7825619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences.
    Borghi L; Meschi T; Guerra A; Novarini A
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S78-86. PubMed ID: 7508066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of sodium cellulose phosphate therapy on crystallization of calcium oxalate in urine.
    Hayashi Y; Kaplan RA; Pak CY
    Metabolism; 1975 Nov; 24(11):1273-8. PubMed ID: 241892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a 5-year treatment program in patients with hyperoxaluric stones.
    Pinto B; Ruiz-Marcellán FJ; Bernshtam J
    J Urol; 1983 Nov; 130(5):943-5. PubMed ID: 6632105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral magnesium load test for the assessment of intestinal magnesium absorption. Application in control subjects, absorptive hypercalciuria, primary hyperparathyroidism, and hypoparathyroidism.
    Nicar MJ; Pak CY
    Miner Electrolyte Metab; 1982 Jul; 8(1):44-51. PubMed ID: 6897741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.